Comments on ICER’s Draft Evidence Report: Modulator Treatments for Cystic Fibrosis
Cystic fibrosis is a devastating disease that severely restricts patients’ quality of life and is associated with a shorter lifespan. The economic costs for managing cystic fibrosis are high. According to the American Thoracic Society, the average cost of care for cystic fibrosis was $48,000 in 2006. A good deal of these costs are costs […]
Crisis of Confidence: My Struggle with Thyroid Eye Disease
I know a thing or two about rebuilding lost confidence.
Taking the Co-pay Out of Coronavirus
The growing threat of coronavirus demands that people get tested if they show flu-like symptoms. Yet some Americans may find it hard to pay for a doctor’s visit, lab testing and treatment.
Funding for a Clearer Future
Good solutions tackle the root of the problem. That’s why advocates are calling for increased federal funding for vision and eye health in Fiscal Year 2021.
The Gout Advice Patients May Not Hear
When it comes to suggestions for managing gout, anyone living with the condition is sure to receive an endless stream of mixed messages.
Could Balanced Pain Management Limit Falls for Seniors?
As outlined in The Journals of Gerontology, researchers found that opioid use is “significantly” linked to an increased risk of falls and fall injuries among seniors.
When Rare Disease is a Family Affair
Watching a family member succumb to a rare and progressive disease is painful. But when that rare disease is genetic, empathy can become anxiety.
What Americans Don’t Know about Vision Health
A recent survey commissioned by the American Academy of Ophthalmology reveals new insights into knowledge gaps surrounding vision and eye health.
A Headache Specialist’s Experience with ICER
y Christopher Gottschalk, MD – What is the value of advanced medicine for a patient living with migraine? It’s not a simple question.
Texans Speak Out on Prior Authorization
In a statewide survey conducted by the Texas Medical Association, people reported that health plans’ practice of requiring approval before covering prescribed drugs and tests was undermining patient care.
